Literature DB >> 31549630

Hypertension and kidney disease progression.

Diego Rigo, Marcelo Orias.   

Abstract

Hypertension is a common finding in patients with chronic kidney disease (CKD) and it is associated with kidney disease progression. Hypertensive nephropathy is a diagnosis, mostly based on clinical suspicion and defines many cases of CKD of unknown etiology. The risk of progression of hypertension-attributed nephropathy seems to have a genetic background as has been demonstrated in African-American patients with APOL1 gene risk variants.

Entities:  

Year:  2020        PMID: 31549630     DOI: 10.5414/CNP92S118

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Huoxue Qianyang Qutan Recipe Protects against Early Renal Damage Induced by Obesity-Related Hypertension via the SIRT1/NF-κB/IL-6 Pathway: Integrating Network Pharmacology and Experimental Validation-Based Strategy.

Authors:  Mingzhu Wang; Jianhua Li; Mingtai Gui; Bo Lu; Lei Yao; Xunjie Zhou; Moyi Shi; Liang Hu; Deyu Fu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-27       Impact factor: 2.650

2.  The IFNγ-PDL1 Pathway Enhances CD8T-DCT Interaction to Promote Hypertension.

Authors:  Lance N Benson; Yunmeng Liu; Xiangting Wang; Yunzhao Xiong; Sung W Rhee; Yunping Guo; Katherine S Deck; Christoph J Mora; Lin-Xi Li; Lu Huang; J Tucker Andrews; Zhiqiang Qin; Robert S Hoover; Benjamin Ko; Ryan M Williams; Daniel A Heller; Edgar A Jaimes; Shengyu Mu
Journal:  Circ Res       Date:  2022-04-18       Impact factor: 23.213

3.  Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  ZhongChi Xu; LiChao Qian; RuGe Niu; Ying Yang; ChunLing Liu; Xin Lin
Journal:  Front Med (Lausanne)       Date:  2022-04-25

4.  Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  YiZhuo Li; Shihai Yan; Lichao Qian; Lihua Wu; Yawei Zheng; Zhuyuan Fang
Journal:  Front Pharmacol       Date:  2020-06-19       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.